Andere talen Atreca, Inc.

Aandelen

BCEL

US04965G1094

Beurs gesloten - OTC Markets Andere beurzen 21:56:24 22-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,085 ^USD	+10,39%		+4,94%	-35,61%

06/02	Atreca, Inc. Kondigt ontslag van de Raad van Bestuur aan	CI
2023	Immunome tekent overeenkomst voor de aankoop van antilichaam-gerelateerde activa van Atreca	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BCEL, CTLT, NS, SCX	18/04
North American Morning Briefing : Stock Futures -2-	17/04
North American Morning Briefing : Traders Await -2-	10/04
Atreca, Inc.(OTCPK:BCEL) dropped from S&P TMI Index	21/03
Atreca, Inc.(OTCPK:BCEL) dropped from NASDAQ Composite Index	18/03
Atreca : Failure to Satisfy Listing Rule - Form 8-K	11/03
Atreca, Inc. Announces Board Resignations	06/02
BCEL Stock Alert: Halper Sadeh LLC Is Investigating Atreca, Inc.	26/12
Immunome Signs Asset Purchase Agreement for Acquisition of Antibody-Related Assets From Atreca	26/12
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome	26/12
Immunome, Inc. entered into an agreement to acquire Substantially all Assets of Atreca, Inc. for $12.5 million.	26/12
Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives	14/11
Atreca, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Atreca, Inc. to Continue Exploring Strategic Alternatives	14/11
Investors Remain Cautious Over Fed Moves, Setting Wall Street Up for Lower Open	20-10-23
Top Premarket Gainers	19-10-23
Intelligent Bio Solutions Inc. (NASDAQ: INBS): "Fingerprint Sweat Analysis: Revolutionizing Drug Screening with Speed and Precision" (JAGX, BCEL, CDIO)	13-10-23
Atreca to Terminate Lease on California Headquarters; Chief Financial Officer Resigns	21-09-23
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross	21-09-23
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross	21-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Atreca, Inc.

Aandelen

BCEL

US04965G1094

Andere talen

Filters